|
1
|
Swaye PS, Fisher LD, Litwin P, Vignola PA,
Judkins MP, Kemp HG, Mudd JG and Gosselin AJ: Aneurysmal coronary
artery disease. Circulation. 67:134–138. 1983.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Baman TS, Cole JH, Devireddy CM and
Sperling LS: Risk factors and outcomes in patients with coronary
artery aneurysms. Am J Cardiol. 93:1549–1551. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Warisawa T, Naganuma T, Tomizawa N, Fujino
Y, Ishiguro H, Tahara S, Kurita N, Nojo T and Nakamura S and
Nakamura S: High prevalence of coronary artery events and
non-coronary events in patients with coronary artery an-eurysm in
the observational group. Int J Cardiol Heart Vasc. 10:29–31.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Markis JE, Joffe CD, Cohn PF, Feen DJ,
Herman MV and Gorlin R: Clinical significance of coronary arterial
ectasia. Am J Cardiol. 37:217–222. 1976.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Aboeata AS, Sontineni SP, Alla VM and
Esterbrooks DJ: Coronary artery ectasia: Current concepts and
interventions. Front Biosci (Elite Ed). 4:300–310. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Doi T, Kataoka Y, Noguchi T, Shibata T,
Nakashima T, Kawakami S, Nakao K, Fujino M, Nagai T, Kanaya T, et
al: Coronary artery ectasia predicts future cardiac events in
patients with acute myocardial infarction. Arterioscler Thromb Vasc
Biol. 37:2350–2355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Saglam M, Karakaya O, Barutcu I, Esen AM,
Turkmen M, Kargin R, Esen O, Ozdemir N and Kaymaz C: Identifying
cardiovascular risk factors in a patient population with coronary
artery ectasia. Angiology. 58:698–703. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kühl M and Varma C: A case of acute
coronary thrombosis in diffuse coronary artery ectasia. J Invasive
Cardiol. 20:E23–E25. 2008.PubMed/NCBI
|
|
9
|
Luo Y, Tang J and Liu X, Qiu J, Ye Z, Lai
Y, Yao Y, Li J, Wang X and Liu X: Coronary artery aneurysm differs
from coronary artery ectasia: Angiographic characteristics and
cardiovascular risk factor analysis in patients referred for
coronary angiography. Angiology. 68:823–830. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Araszkiewicz A, Grygier M, Lesiak M and
Grajek S: From positive remodelling to coronary artery ectasia. Is
coronary artery aneurysm a benign form of coronary disease? Kardiol
Pol. 67:1390–1395. 2009.PubMed/NCBI(In Polish).
|
|
11
|
Wojciechowska A, Braniewska A and
Kozar-Kamińska K: MicroRNA in cardiovascular biology and disease.
Adv Clin Exp Med. 26:865–874. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Barwari T, Joshi A and Mayr M: MicroRNAs
in cardiovascular disease. J Am Coll Cardiol. 68:2577–2584.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Montgomery RL and van Rooij E: MicroRNA
regulation as a therapeutic strategy for cardiovascular disease.
Curr Drug Targets. 11:936–942. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Viereck J and Thum T: Circulating
noncoding RNAs as biomarkers of cardiovascular disease and injury.
Circ Res. 120:381–399. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kumar S, Boon RA, Maegdefessel L, Dimmeler
S and Jo H: Role of noncoding RNAs in the pathogenesis of abdominal
aortic aneurysm. Circ Res. 124:619–630. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rowley AH, Pink AJ, Reindel R, Innocentini
N, Baker SC, Shulman ST and Kim KY: A study of cardiovascular miRNA
biomarkers for Kawasaki disease. Pediatr Infect Dis J.
33:1296–1299. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chu M, Wu R, Qin S, Hua W, Shan Z, Rong X,
Zeng J, Hong L, Sun Y, Liu Y, et al: Bone marrow-derived
Mi-croRNA-223 works as an endocrine genetic signal in vascular
endothelial cells and participates in vascular injury from kawasaki
disease. J Am Heart Assoc. 6(e004878)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bang C, Fiedler J and Thum T:
Cardiovascular importance of the microRNA-23/27/24 family.
Microcirculation. 19:208–214. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang H, Bian C, Tu S, Yin F, Guo P, Zhang
J, Wu Y, Yin Y, Gou J and Han Y: Construction of the
circRNA-miRNA-mRNA regulatory network of an abdominal aortic
aneurysm to explore its potential pathogenesis. Dis Markers.
2021(9916881)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li T, Wang T, Yan L and Ma C:
Identification of potential novel biomarkers for abdominal aortic
aneurysm based on comprehensive analysis of circRNA-miRNA-mRNA
networks. Exp Ther Med. 22(1468)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shimizu C, Kim J, Stepanowsky P, Trinh C,
Lau HD, Akers JC, Chen C, Kanegaye JT, Tremoulet A, Ohno-Machado L
and Burns JC: Differential expression of miR-145 in children with
Kawasaki disease. PLoS One. 8(e58159)2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li R, Liang P, Yuan J and He F: Exosomal
miR-103a-3p ameliorates lipopolysaccharide-induced immune response
in BEAS-2B cells via NF-κB pathway by targeting transducin β-like
1X related protein 1. Clin Exp Pharmacol Physiol. 47:620–627.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Allantaz F, Cheng DT, Bergauer T,
Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H,
D'Asaro M, et al: Expression profiling of human immune cell subsets
identifies miRNA-mRNA regulatory relationships correlated with cell
type specific expression. PLoS One. 7(e29979)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Plana E, Gálvez L, Medina P, Navarro S,
Fornés-Ferrer V, Panadero J and Miralles M: Identification of Novel
microRNA Profiles Dysregulated in Plasma and Tissue of Abdominal
Aortic Aneurysm Patients. Int J Mol Sci. 21(4600)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gou L, Xue C, Tang X and Fang Z:
Inhibition of Exo-miR-19a-3p derived from cardiomyocytes promotes
angiogenesis and improves heart function in mice with myocardial
infarction via targeting HIF-α. Aging (Albany NY). 12:23609–23618.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen C, Ponnusamy M, Liu C, Gao J, Wang K
and Li P: MicroRNA as a therapeutic target in cardiac remodeling.
Biomed Res Int. 2017(1278436)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kim H, Yang JM, Jin Y, Jheon S, Kim K, Lee
CT, Chung JH and Paik JH: MicroRNA expression profiles and
clinicopathological implications in lung adenocarcinoma according
to EGFR, KRAS, and ALK status. Oncotarget. 8:8484–8498.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu
Q, Deitch EA, Huo Y, Delphin ES and Zhang C: MicroRNA-145, a novel
smooth muscle cell phenotypic marker and modulator, controls
vascular neointimal lesion formation. Circ Res. 105:158–166.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gatsiou A, Boeckel JN, Randriamboavonjy V
and Stellos K: MicroRNAs in platelet biogenesis and function:
Implications in vascular homeostasis and inflammation. Curr Vasc
Pharmacol. 10:524–531. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Neumann FJ, Sousa-Uva M, Ahlsson A,
Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V,
Head SJ, et al: 2018 ESC/EACTS guidelines on myocardial
revascularization. Eur Heart J. 40:87–165. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Camps C, Buffa FM, Colella S, Moore J,
Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ragoussis J:
hsa-miR-210 Is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348.
2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fasanaro P, D'Alessandra Y, Di Stefano V,
Melchionna R, Romani S, Pompilio G, Capogrossi MC and Martelli F:
MicroRNA-210 modulates endothelial cell response to hypoxia and
inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol
Chem. 283:15878–15883. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hu S, Huang M, Li Z, Jia F, Ghosh Z,
Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, et al:
MicroRNA-210 as a novel therapy for treatment of ischemic heart
disease. Circulation. 122 (11 Suppl):S124–S131. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo
F, Cui SP, Deng ZF and Wang Y: Upregulation of microRNA-210
regulates renal angiogenesis mediated by activation of VEGF
signaling pathway under ischemia/perfusion injury in vivo and in
vitro. Kidney Blood Press Res. 35:182–191. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cai W and Schaper W: Mechanisms of
arteriogenesis. Acta Biochim Biophys Sin (Shanghai). 40:681–692.
2008.PubMed/NCBI
|
|
38
|
Paulus P, Jennewein C and Zacharowski K:
Biomarkers of endothelial dysfunction: Can they help us deciphering
systemic inflammation and sepsis? Biomarkers. 16 (Suppl 1):S11–S21.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Qin X and Guo J: MicroRNA-328-3p protects
vascular endothelial cells against oxidized low-density lipoprotein
induced injury via targeting forkhead box protein O4 (FOXO4) in
atherosclerosis. Med Sci Monit. 26(e921877)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ma W, Ma CN, Zhou NN, Li XD and Zhang YJ:
Upregulation of miR-328-3p sensitizes non-small cell lung cancer to
radiotherapy. Sci Rep. 6(31651)2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan
M, Xue W, Wang Y, Li W, Shu Y, et al: Exosomal transfer of
cisplatin-induced miR-425-3p confers cisplatin resistance in NSCLC
through activating autophagy. Int J Nanomedicine. 14:8121–8132.
2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shi J, An G, Guan Y, Wei T, Peng Z, Liang
M and Wang Y: miR-328-3p mediates the anti-tumor effect in
osteosarcoma via directly targeting MMP-16. Cancer Cell Int.
19(104)2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yan T and Ye XX: MicroRNA-328-3p inhibits
the tumorigenesis of bladder cancer through targeting ITGA5 and
inactivating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci.
23:5139–5148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yuwen D, Ma Y, Wang D, Gao J, Li X, Xue W,
Fan M, Xu Q, Shen Y and Shu Y: prognostic role of circulating
exosomal miR-425-3p for the response of NSCLC to platinum-based
chemotherapy. Cancer Epidemiol Biomarkers Prev. 28:163–173.
2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Courtois A, Nusgens B, Garbacki N, Hustinx
R, Gomez P, Defraigne JO, Colige AC and Sakalihasan N: Circulating
microRNAs signature correlates with positive
[18F]fluorodeoxyglucose-positron emission tomography in
patients with abdominal aortic aneurysm. J Vasc Surg. 67:585–595
e3. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Xiao Y, Zhao J, Tuazon JP, Borlongan CV
and Yu G: MicroRNA-133a and myocardial infarction. Cell Transplant.
28:831–838. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Qiao Y, Ma N, Wang X, Hui Y, Li F, Xiang
Y, Zhou J, Zou C, Jin J, Lv G, et al: MiR-483-5p controls
angiogenesis in vitro and targets serum response factor. FEBS Lett.
585:3095–3100. 2011.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Li S, Lee C, Song J, Lu C, Liu J, Cui Y,
Liang H, Cao C, Zhang F and Chen H: Circulating microRNAs as
potential biomarkers for coronary plaque rupture. Oncotarget.
8:48145–48156. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chmielewski S, Olejnik A, Sikorski K,
Pelisek J, Błaszczyk K, Aoqui C, Nowicka H, Zernecke A, Heemann U,
Wesoly J, et al: STAT1-dependent signal integration between IFNү
and TLR4 in vascular cells reflect pro-atherogenic responses in
human atherosclerosis. PLoS One. 9(e113318)2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chmielewski S, Piaszyk-Borychowska A,
Wesoly J and Bluyssen HA: STAT1 and IRF8 in vascular inflammation
and cardiovascular disease: Diagnostic and therapeutic potential.
Int Rev Immunol. 35:434–454. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liu L, Cheng Z and Yang J: miR-23
regulates cell proliferation and apoptosis of vascular smooth
muscle cells in coronary heart disease. Pathol Res Pract.
214:1873–1878. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Li X, Teng C, Ma J, Fu N, Wang L, Wen J
and Wang TY: miR-19 family: A promising biomarker and therapeutic
target in heart, vessels and neurons. Life Sci.
232(116651)2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chen L, Lu Q, Deng F, Peng S, Yuan J, Liu
C and Du X: miR-103a-3p Could attenuate sepsis-induced liver injury
by targeting HMGB1. Inflammation. 43:2075–2086. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rangrez AY, Massy ZA, Metzinger-Le Meuth V
and Metzinger L: miR-143 and miR-145: Molecular keys to switch the
phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet.
4:197–205. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI View Article : Google Scholar
|
|
56
|
He M, Chen Z, Martin M, Zhang J, Sangwung
P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC and Shyy JY:
miR-483 Targeting of CTGF suppresses endothelial-to-mesenchymal
transition: Therapeutic implications in kawasaki disease. Circ Res.
120:354–365. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Serafin A, Foco L, Zanigni S, Blankenburg
H, Picard A, Zanon A, Giannini G, Pichler I, Facheris MF, Cortelli
P, et al: Overexpression of blood microRNAs 103a, 30b, and 29a in
L-dopa-treated patients with PD. Neurology. 84:645–653.
2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lu Q, Ma Z, Ding Y, Bedarida T, Chen L,
Xie Z, Song P and Zou MH: Circulating miR-103a-3p contributes to
angiotensin II-induced renal inflammation and fibrosis via a
SNRK/NF-κB/p65 regulatory axis. Nat Commun. 10(2145)2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Jiao T, Yao Y, Zhang B, Hao DC, Sun QF, Li
JB, Yuan C, Jing B, Wang YP and Wang HY: Role of Mi-croRNA-103a
Targeting ADAM10 in abdominal aortic aneurysm. Biomed Res Int.
2017(9645874)2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Cerna V, Ostasov P, Pitule P, Mollacek J,
Treska V and Pesta M: The expression profile of MicroRNAs in small
and large abdominal aortic aneurysms. Cardiol Res Pract.
2019(8645840)2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Elia L, Quintavalle M, Zhang J, Contu R,
Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J,
et al: The knockout of miR-143 and -145 alters smooth muscle cell
maintenance and vascular homeostasis in mice: Correlates with human
disease. Cell Death Differ. 16:1590–1598. 2009.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Wang Z, Zhuang X, Chen B, Feng D, Li G and
Wei M: The role of miR-107 as a potential biomarker and cellular
factor for acute aortic dissection. DNA Cell Biol. 39:1895–1906.
2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Shimizu C, Oharaseki T, Takahashi K,
Kottek A, Franco A and Burns JC: The role of TGF-β and
myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol.
44:189–198. 2013.PubMed/NCBI View Article : Google Scholar
|
